Delivery Order SPE2DB20D3505-SPE2DB24FU6N3

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,673.08, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of December 13, 2023. The award is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,478.23 firm fixed-price delivery order is for TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a period of performance through January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 500S, a pharmaceutical product, with a ceiling value of $1,559.49. The contract has a firm fixed price pricing type and an ultimate completion date of June 13, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,735.89, is a delivery order for the supply of 4567732559 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a firm fixed-price agreement with an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,290.92 firm fixed-price delivery order is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 100S, with a completion date of March 18, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,060.04 Firm Fixed Price Delivery Order is for the supply of 4,563,337,812 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 17, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.10, is for the supply of 4567645234 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order contract. This contract award is not designated as a set-aside. AmerisourceBergen...
This is a $11,708.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4565020557 - TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a performance period through June 28, 2024. Amerisourcebergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award, valued at $15,804.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication, to support military treatment programs and facilities. The contract has a firm fixed-price pricing type and an ultimate completion date of September 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,874.65, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU6N3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565214153 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price of $1,062.78 and an ultimate completion date of July 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 10/17/24, 9:19 AM